ZELTIQ Aesthetics, Inc.

( )
ZLTQ After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
TMOThermo Fisher Scientific, Inc. 0.64%470.771.0%$739.18m
ABTAbbott Laboratories 0.29%118.850.8%$608.52m
DHRDanaher Corp. 0.97%256.960.7%$569.61m
MDTMedtronic Plc 0.18%127.230.6%$561.46m
ISRGIntuitive Surgical, Inc. 0.48%842.462.3%$487.78m
BSXBoston Scientific Corp. -0.05%43.071.0%$351.26m
ALGNAlign Technology, Inc. 2.72%584.726.3%$328.32m
BDXBecton, Dickinson & Co. -3.46%241.141.0%$319.10m
NVCRNovoCure Ltd. -4.02%193.656.8%$314.36m
SYKStryker Corp. 0.44%254.191.3%$270.73m
EWEdwards Lifesciences Corp. -0.07%91.710.4%$267.36m
DXCMDexCom, Inc. -2.35%357.347.8%$253.43m
AAgilent Technologies, Inc. -0.65%132.511.6%$207.05m
BAXBaxter International, Inc. 0.89%87.471.8%$187.10m
NVSTEnvista Holdings Corp. 4.67%44.840.0%$183.95m

Company Profile

Zeltiq (pronounced Zel ′teek) Aesthetics, founded in 2005, is a science-based medical device company dedicated to the development of non-invasive procedures for the reduction of unwanted fat tissue. The Zeltiq approach utilizes a patented method called Cryolipolysis™ (the use of precisely controlled cooling to remove fat) that is designed to target only fat cells and not harm the skin or other tissue. The Zeltiq device is cleared by the FDA in the Unites States for various applications related to skin cooling during dermatologic treatments.